Compassionate Use Statement
Expanded access, or compassionate use, is the use of an investigational medicine prior to regulatory approval and outside of a clinical trial.
Surface Oncology does not currently have an expanded access program or compassionate use program for any of our investigational products.
We understand that for patients with serious diseases such as cancer, waiting for an approved treatment can be difficult. We believe that devoting ourselves to current and future clinical trial programs provides the best path to meet our goal of providing therapeutics to patients with cancer.
We encourage you to speak with your physician about options that may be right for you.